ArticleBMC public health2025

Is the domestic bivalent HPV vaccine cost-effective compared with quadrivalent or nine-valent HPV vaccines in the context of cervical cancer screening? A modeling study.

Liangwen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.